Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
CAPS Rating:
A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.
RSS Headlines
Fool UK
Recs
Priced at near cash on hand, with bright prospects in the coming years.